Transparent pricing
Patients with T2DM, persons at risk for AD, had a significantly lower associated risk of AD after administered exenatide, liraglutide and dulaglutide ( Conclusion Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms in AD models, such as anti-inflammation, anti-oxidative stress, reducing A aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects
Why are GLP-1 agonists so groundbreaking
Three Times Weekly: You divide the weekly dose into thirds and inject on Monday, Wednesday, and Friday
The gap between your current weight and your pre-pregnancy weight starts closing in a way that feels real rather than aspirational